文献速递骨质疏松与钙磷/甲状旁腺糖尿病

糖尿病病程较长强烈影响骨折风险评估:马尼托巴骨密度队列研究

Longer Duration of Diabetes Strongly Impacts Fracture Risk Assessment: The Manitoba BMD Cohort.
PubMed 文献 · J Clin Endocrinol Metab · 2016-09-07

该研究利用马尼托巴骨密度登记与行政数据库,纳入40岁以上接受髋部双能X线吸收测量法的女性,分析糖尿病病程对骨折风险的影响。结果显示,仅糖尿病病程超过10年者主要骨质疏松性骨折风险升高(FRAX校正后HR 1.47),而髋部骨折风险随病程延长呈剂量依赖性升高。FRAX显著低估病程超过10年者的骨折风险。

要点

  • 糖尿病病程超过10年者主要骨质疏松性骨折风险升高,FRAX校正后HR 1.47。
  • 髋部骨折风险随糖尿病病程延长呈剂量依赖性升高,新发糖尿病FRAX校正后HR 1.32。
  • FRAX低估病程超过10年者的主要骨质疏松性骨折和髋部骨折风险。

核心结论

  • 糖尿病仅在女性病程较长时是独立于FRAX的主要骨质疏松性骨折危险因素,但无论病程长短均增加髋部骨折风险。
  • 病程超过10年者骨折风险尤其高,而FRAX目前低估了这一风险。

研究设计与样本

  • 利用马尼托巴临床双能X线吸收测量法登记与行政数据库链接,识别所有40岁及以上、有10年以上既往医疗覆盖、接受髋部双能X线吸收测量法的女性(1996-2013年)。
  • 共纳入49 098名无糖尿病女性和8840名糖尿病女性,其中31.4%病程超过10年,20.1%为5-10年,23.7%小于5年,24.8%为新发。
  • 分别研究7年内主要骨质疏松性骨折和髋部骨折的发生情况,采用Cox比例风险模型进行FRAX校正和完全校正。

主要发现

  • 在FRAX校正分析中,仅病程超过10年与主要骨质疏松性骨折风险升高相关(HR 1.47,95%CI 1.30-1.66),完全校正模型结果相似(HR 1.34,95%CI 1.17-1.54)。
  • 髋部骨折风险在所有糖尿病病程中均呈剂量依赖性升高,例如FRAX校正后病程超过10年HR 2.10(95%CI 1.71-2.59),新发糖尿病HR 1.32(95%CI 1.03-1.69)。
  • FRAX显著低估病程超过10年者的主要骨质疏松性骨折风险(校准比1.24,95%CI 1.08-1.39)和髋部骨折风险(校准比1.93,95%CI 1.50-2.35)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Type 2 diabetes is associated with a higher risk for major osteoporotic fracture (MOF) and hip fracture than predicted by the World Health Organization fracture risk assessment (FRAX) tool. OBJECTIVE: The objective of the study was to examine the impact of diabetes duration on fracture risk. METHODS: Using a clinical dual-energy x-ray absorptiometry registry linked with the Manitoba administrative databases, we identified all women age 40 years or older with 10 or more years of prior health care coverage undergoing hip dual-energy x-ray absorptiometry measurements (1996-2013). Incident MOF and incident hip fractures were each studied over 7 years. Cox proportional hazards models were adjusted for FRAX (FRAX adjusted) and then FRAX plus comorbidity, falls, osteoporosis therapy, or insulin (fully adjusted). FRAX calibration was assessed comparing observed vs predicted probabilities. RESULTS: There were 49 098 women without and 8840 women with diabetes (31.4% >10 y duration; 20.1% 5-10 y; 23.7% <5 y; 24.8% new onset). In FRAX-adjusted analyses, only duration longer than 10 years was associated with a higher risk for MOF (hazard ratio [HR] 1.47, 95% confidence interval [CI] 1.30-1.66), and this was similar in the fully adjusted models (HR 1.34, 95% CI 1.17-1.54). In contrast, a higher risk for hip fracture was seen for all durations in a dose-dependent fashion (eg, FRAX adjusted HR 2.10, 95% CI 1.71-2.59 for duration >10 y vs HR 1.32, 95% CI 1.03-1.69 for new onset). FRAX significantly underestimated the MOF risk (calibration ratio 1.24, 95% CI 1.08-1.39) and hip fracture risk (1.93, 95% CI 1.50-2.35) in those with a diabetes duration longer than 10 years. CONCLUSION: Diabetes is a FRAX-independent risk factor for MOF only in women with a long duration of diabetes, but diabetes increases hip fracture risk, regardless of duration. Those with diabetes longer than 10 years are at particularly high risk of fracture, and this elevated risk is currently underestimated by FRAX.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Majumdar SR, Leslie WD, Lix LM, et al. Longer Duration of Diabetes Strongly Impacts Fracture Risk Assessment: The Manitoba BMD Cohort. J Clin Endocrinol Metab. 2016. PMID: 27603908

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。